The Effect of Iyengar Yoga Practice on Patients With Multiple Sclerosis

Sponsor
University Hospital, Motol (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05247372
Collaborator
(none)
5
1
1
12.2
0.4

Study Details

Study Description

Brief Summary

The aim of this work is to find out what effect the practice of Iyengar yoga has on patients with multiple sclerosis on the EDSS 5 and more, specifically in the field of mobility, self-sufficiency and anxiety.

Condition or Disease Intervention/Treatment Phase
  • Other: The effect of Iyengar yoga practice on patients with multiple sclerosis
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
5 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Effect of Iyengar Yoga Practice on Patients With Multiple Sclerosis
Actual Study Start Date :
Jun 25, 2021
Anticipated Primary Completion Date :
Jun 30, 2022
Anticipated Study Completion Date :
Jun 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Other: The effect of Iyengar yoga practice on patients with multiple sclerosis

Other: The effect of Iyengar yoga practice on patients with multiple sclerosis
The study will be conducted as a longitudinal follow-up - at first patients will fbe examined 2 months before the start of the exercise, than they will be examined at the beginning and end of the exercise, which they will attend for 3 months. Patients will be re-examined 2 months after the end of the exercise to clarify the continuing effect of the exercise. The examination will include a basic kinesiological analysis and a neurological examination,TUG test, 6MWT along with the Borg Subjective Weight Rating Scale and T25FWT, BBS, NHPT and stable sitting time in wheelchairs. To evaluate the development of the chest, the respiratory amplitude will be examined and the position of the spine in statics and dynamics will be evaluated using a spinal mouse. Quality of life will be assessed through the MFIS, MSIS-29, MSQOL 54 questionares and Beck's anxiety inventory.

Outcome Measures

Primary Outcome Measures

  1. Hypothesis 1 [3 months]

    Increase in respiratory amplitud. It will be measured by the meter.

  2. Hypothesis 2 [3 months]

    Increase in spinal development in the sagittal and frontal plane. It will by measured by spinal mouse.

  3. Hypothesis 3 [3 months]

    Increase in walking speed measured by T25FWT. It will by measured by stopwatch.

  4. Hypothesis 4 [3 months]

    Balance improvement in the Berg balance scale. It will be measured by the Berg balance scale questionare.

  5. Hypothesis 5 [3 months]

    The quality of life of patients with MS is improved subjectively evaluated through MSQOL54 questionare.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • age over 18 years

  • diagnosis of multiple sclerosis

  • EDSS grade 5 or higher

Exclusion Criteria:
  • age less than 18 years

  • the patient is not diagnosed with multiple sclerosis EDSS grade less than 5

  • refusal of the subject to participate in the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospital Motol Prague Czech Republic Czechia 15006

Sponsors and Collaborators

  • University Hospital, Motol

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Stanislav Machač, Ph.D, Principal Investigator, University Hospital, Motol
ClinicalTrials.gov Identifier:
NCT05247372
Other Study ID Numbers:
  • EK-809/21
First Posted:
Feb 18, 2022
Last Update Posted:
Mar 28, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 28, 2022